Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Carlos Abraira"'
Autor:
William C, Duckworth, Carlos, Abraira, Thomas E, Moritz, Stephen N, Davis, Nicholas, Emanuele, Steven, Goldman, Rodney, Hayward, Grant D, Huang, Jennifer B, Marks, Peter D, Reaven, Domenic J, Reda, Stuart R, Warren, Franklin J, Zieve, Virginia, Easton
Publikováno v:
Journal of Diabetes and its Complications. 25:355-361
The goal of the VA Diabetes Trial (VADT) was to determine the effect of intensive glucose control on macrovascular events in subjects with difficult-to-control diabetes. No significant benefit was found. This report examines predictors of the effect
Autor:
Derrick G. Kaufman, Nicholas V. Emanuele, Gideon D. Bahn, Carlos Abraira, N. Azad, Thomas E. Moritz, William C. Duckworth, Lily Agrawal
Publikováno v:
Diabetes Care
OBJECTIVE The Veterans Affairs Diabetes Trial (VADT) was a randomized, prospective, controlled trial of 1,791 patients with type 2 diabetes to determine whether intensive glycemic control would reduce cardiovascular events compared with standard cont
Autor:
Robert J. Anderson, Gideon D. Bahn, William C. Duckworth, Derrick G. Kaufman, Carlos Abraira, Thomas E. Moritz
Publikováno v:
Diabetes Care
OBJECTIVE Blood pressure ranges associated with cardiovascular disease (CVD) events in advanced type 2 diabetes are not clear. Our objective was to determine whether baseline and follow-up (On-Study) systolic blood pressure (SBP), diastolic blood pre
Autor:
Aramesh Saremi, Carlos Abraira, William C. Duckworth, Peter D. Reaven, Thomas E. Moritz, Robert J. Anderson
Publikováno v:
Diabetes Care
OBJECTIVE To determine the predictors of progression of calcified atherosclerosis and the effect of intensive glycemic control on this process in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS As part of the Risk Factors, Atherosclerosis,
Publikováno v:
Primary Care Diabetes. 4:S3-S10
The treatment of type 2 diabetes is shifting from secondary specialist centres to the primary care setting. However, for this shift to be sustainable and successful, primary care physicians (PCPs) must effectively provide aspects of diabetes care tra
Autor:
Nicholas, Emanuele, Ronald, Klein, Thomas, Moritz, Matthew D, Davis, Kathleen, Glander, Robert, Anderson, Domenic, Reda, William, Duckworth, Carlos, Abraira, Lynne A, Gurnsey
Publikováno v:
Journal of Diabetes and its Complications. 23:323-329
Objective The Veterans Affairs Diabetes Trial (VADT) is a 20-medical center, prospective, randomized study of 1792 Type 2 diabetic individuals primarily aimed at determining whether intensive glycemic control prevents macrovascular events. We report
Publikováno v:
Diabetes, Obesity and Metabolism. 11:150-156
Objective: The Veterans Affairs Diabetes Trial (VADT) will assess the effect of intensive (INT) vs improved standard (STD) glycaemic control on major cardiovascular (CV) events, treating other risk factors equally in both arms. Four-year results of m
Autor:
William, Duckworth, Carlos, Abraira, Thomas, Moritz, Domenic, Reda, Nicholas, Emanuele, Peter D, Reaven, Franklin J, Zieve, Jennifer, Marks, Stephen N, Davis, Rodney, Hayward, Stuart R, Warren, Steven, Goldman, Madeline, McCarren, Mary Ellen, Vitek, William G, Henderson, Grant D, Huang, V, Easton
Publikováno v:
New England Journal of Medicine. 360:129-139
The effects of intensive glucose control on cardiovascular events in patients with long-standing type 2 diabetes mellitus remain uncertain.We randomly assigned 1791 military veterans (mean age, 60.4 years) who had a suboptimal response to therapy for
Publikováno v:
Journal of Diabetes and its Complications. 20:75-80
The problem Macrovascular disease (MVD), especially coronary heart disease, is the most common cause of mortality in Type 2 diabetes. We assessed the association between demographic and clinical variables (particularly HbA1c) and prevalent MVD at tim
Autor:
Domenic J. Reda, Carlos Abraira, Ronald Klein, Nicholas V. Emanuele, Jerome Sacks, Robert J. Anderson, William C. Duckworth
Publikováno v:
Diabetes Care. 28:1954-1958
OBJECTIVE—The Veterans Affairs Diabetes Trial (VADT) cohort is enriched with ∼20% Hispanics and 20% African Americans, affording a unique opportunity to study ethnic differences in retinopathy. RESEARCH DESIGN AND METHODS—Cross-sectional analys